NASDAQ:GRCL
Delisted

Gracell Biotechnologies Stock Signals

etoro logo Buy GRCL
*Your capital is at risk
$10.25
+0 (+0%)
At Close: May 20, 2024

Latest Data & Signals Issued

Below are some of the latest signals issued for Gracell Biotechnologies Inc.

General

Signal Type Signal Value Data
Score 0.000 144 days ( -236.07 %
Last Price $10.25 0 %
Performance History
7 Days
$10.25 $10.25
0%
30 Days
$10.25 $10.25
0%
12 Mos
$2.38 $10.25
330.67%

8/18

Active Buy Signals

Specific Signals

Short Term
Net score: 45.27
Signal Type Signal Value Importance Data
High / Low N/A Very Low $10.25 - $10.25
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low May 17, 2024 - 2 days
RSI Short Pivot Signal Sell Very Low Mar 07, 2024 - 52 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Buy Medium Apr 01, 2024 - 36 days
Short/Long MA 3 mos Buy Medium Apr 01, 2024 - 36 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 74.41
Signal Type Signal Value Importance Data
Trend - 12 mos 171.26 % Very High Width: 84.65 %
Pred. range - 12 mos $21.93 - $40.50 High 114.00 % - 295.15 %
Short MA 12 mos Buy Very High Mar 11, 2024 - 50 days
Long MA 12 mos Buy Very High Oct 31, 2023 - 139 days
Short/Long MA 12 mos Buy Very High Nov 13, 2023 - 130 days
Pivot Long Sell Low Feb 09, 2024 - 70 days
RSI Long Pivot Signal Sell Low Mar 18, 2024 - 45 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT GRACELL BIOTECHNOLOGIES INC.
Gracell Biotechnologies
Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the treatment of multiple myeloma; GC019F, a FasTCAR-enabled CD19-directed autologous CAR-T product candidate,...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE